Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopamine receptor agonists for treating prolactinomas.

Annamaria Colao1, Antonella di Sarno, Rosario Pivonello

  • 1Department of Molecular and Clinical Endocrinology and Oncology, Federico II University of Naples, via S. Pansini 5, 80131 Naples, Italy. colao@unina.it

Expert Opinion on Investigational Drugs
|May 31, 2002
PubMed
Summary

Cabergoline effectively treats hyperprolactinemic disorders by suppressing prolactin secretion and shrinking tumors. This ergoline derivative is well-tolerated and superior to bromocriptine, making it a preferred treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient empowerment and the Mediterranean diet as a possible tool to tackle prediabetes associated with overweight or obesity: a pilot study.

Hormones (Athens, Greece)·2019
Same author

Immune checkpoint blockade for Merkel cell carcinoma: actual findings and unanswered questions.

Journal of cancer research and clinical oncology·2019
Same author

Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules.

Chemosphere·2019
Same author

Role of Nutrition and Adherence to the Mediterranean Diet in the Multidisciplinary Approach of Hidradenitis Suppurativa: Evaluation of Nutritional Status and Its Association with Severity of Disease.

Nutrients·2019
Same author

Gender-related issues in the pharmacology of new anti-obesity drugs.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2018
Same author

Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome.

Nutrients·2018

Area of Science:

  • Endocrinology
  • Pharmacology
  • Oncology

Background:

  • Prolactinomas are common pituitary tumors causing hormonal dysfunction.
  • Dopaminergic drugs have revolutionized prolactinoma treatment.
  • Cabergoline is a potent ergoline derivative for hyperprolactinemia.

Purpose of the Study:

  • To evaluate cabergoline's efficacy and tolerability in treating hyperprolactinemic disorders.
  • To compare cabergoline with bromocriptine for hyperprolactinemia management.
  • To assess cabergoline's impact on tumor size and pregnancy outcomes.

Main Methods:

  • Clinical studies comparing cabergoline and bromocriptine.
  • Assessment of prolactin levels, tumor response, and patient tolerability.
  • Review of pregnancy data associated with cabergoline use.

Related Experiment Videos

Main Results:

  • Cabergoline demonstrated superior efficacy and tolerability compared to bromocriptine.
  • Significant tumor shrinkage, including disappearance, was observed with cabergoline.
  • Cabergoline proved effective in bromocriptine-resistant cases.

Conclusions:

  • Cabergoline is the current treatment of choice for most hyperprolactinemic disorders due to its efficacy and tolerability.
  • While pregnancy data is limited, no adverse effects on pregnancy or offspring have been reported.
  • Discontinuation of cabergoline is recommended one month prior to conception attempts.